Cyclerion Therapeutics, Inc. (CYCN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Cyclerion Therapeutics, Inc. (CYCN) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

CYCN Cash Flow Statement

Cyclerion Therapeutics, Inc. (CYCN) cash flow statement — 9-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-1.43M	-1.18M	-1.58M	-264K	-503K	-968K	360K	-1.72M	-1.11M	-1.87M	-1.54M	-6.93M	-6.55M	-6.21M	-7.04M	-9.91M	-10.82M	-12.84M	-8.63M	-7.92M
Operating CF Margin %	-	-	-154.05%	-30.17%	-540.86%	-1195.06%	19.93%	-884.54%	-	-	-	-	-	-	-	-	-3535.29%	-1805.2%	-1619.14%	-2276.72%
Operating CF Growth %	-184.69%	-21.49%	-538.61%	84.62%	54.52%	48.26%	123.36%	75.26%	83.13%	69.89%	78.12%	30.06%	39.41%	51.59%	18.39%	-25.14%	-96.37%	11.21%	38.54%	47.35%
Net Income	-1.75M	-3.18M	-799K	-976K	-324K	-1.43M	530K	-723K	-1.32M	-1.54M	-1.69M	7.57M	-1.8M	-6.95M	-4.32M	-10.5M	-13.39M	-12.98M	-10.78M	-11.29M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17K	48K	48K	600K
Stock-Based Compensation	109K	0	0	118K	114K	114K	122K	138K	184K	181K	103K	159K	0	426K	0	1.66M	1.7M	1.77M	2.55M	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-58K	58K	95K	0	0	0	0	-363K	0	0	0	-12.45M	-2M	0	-1.77M	0	0	0	-3.56M	1.86M
Working Capital Changes	272K	1.94M	-875K	594K	-293K	347K	-292K	-768K	32K	-510K	50K	-2.21M	-2.75M	314K	-951K	-1.08M	854K	-1.67M	3.11M	908K
Change in Receivables	0	1M	-900K	425K	56K	-25K	-512K	-44K	0	0	0	0	96K	0	131K	0	0	-127K	58K	-158K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.14M	-51K	28K	18K	-21K	93K	86K	16K	-91K	-456K	385K	-1.05M	-2.06M	955K	1.32M	-1.12M	248K	691K	654K	-212K
Cash from Investing	0	-66K	0	0	0	0	0	0	0	0	0	10.4M	0	0	0	0	0	0	0	-7K
Capital Expenditures	0	-66K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-7K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.01%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	10.4M	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	0	825K	251K	1.83M	-130K	1.38M	0	0	0	0	0	0	5.02M	0	12K	0	17K	0	85K	43K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	825K	251K	1.83M	-130K	1.38M	0	0	0	0	0	0	5.02M	0	12K	0	17K	0	85K	37K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6K
Net Change in Cash	-1.43M	-417K	-1.33M	1.56M	-633K	407K	360K	-1.72M	-1.11M	-1.88M	-1.54M	3.47M	-1.53M	-6.21M	-7.02M	-9.92M	-10.8M	-12.84M	-8.54M	-7.89M
Free Cash Flow	-1.37M	-1.24M	-1.58M	-264K	-503K	-968K	360K	-1.72M	-1.11M	-1.87M	-1.54M	-6.93M	-6.55M	-6.21M	-7.04M	-9.91M	-10.82M	-12.84M	-8.63M	-7.93M
FCF Margin %	-	-	-154.05%	-30.17%	-540.86%	-1195.06%	19.93%	-884.54%	-	-	-	-	-	-	-	-	-3535.29%	-1805.2%	-1619.14%	-2278.74%
FCF Growth %	-171.57%	-28.31%	-538.61%	84.62%	54.52%	48.26%	123.36%	75.26%	83.13%	69.89%	78.12%	30.06%	39.41%	51.59%	18.39%	-25.03%	-96.37%	11.21%	38.69%	47.33%
FCF per Share	-2.25	-2.07	-3.43	-0.57	-1.15	-2.65	0.99	-4.76	-3.08	-5.25	-0.62	-2.85	-2.87	-2.86	-3.24	-4.80	-5.23	-6.21	-4.19	-3.66
FCF Conversion (FCF/Net Income)	0.82x	0.37x	1.98x	0.27x	1.55x	0.68x	0.68x	2.37x	0.84x	1.21x	0.91x	-0.92x	1.57x	0.89x	0.98x	0.94x	0.81x	0.99x	0.80x	0.70x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0